RA
RBOT

Ramius Advisors’s Vicarious Surgical RBOT Stock Holding History

Ramius Advisors’s Portfolio RBOT Stock Details RBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-8,827
Closed -$2.63M – 300
2021
Q1 		$2.63M Sell
8,827
-10,679
-55% -$3.27M 0.7% 46
2020
Q4 		$5.95M Buy
+19,506
New +$5.73M 2.2% 11

Other funds holding RBOT

PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
AC
Athanor Capital New York $24.6M AUM 2.49% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Capstone Investment Advisors
Capstone Investment Advisors New York $57.4B AUM 26.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
SCM
Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return

Ramius Advisors's RBOT Position: Q2 2021 in Review

Ramius Advisors sold out of Vicarious Surgical (RBOT) in Q2 2021, closing a stake of 8,827 shares — an estimated $2.63M sold.

Ramius Advisors first reported a position in RBOT in Q4 2020 and held it in 2 quarters. The position peaked at $5.95M in Q4 2020. 98 funds tracked by Wall St. Rank hold RBOT as of Q2 2021.

  • Ramius Advisors reported no remaining Vicarious Surgical position as of Q2 2021 after selling out during the quarter.
  • Ramius Advisors sold 8,827 Vicarious Surgical shares in Q2 2021, an estimated $2.63M.
  • Ramius Advisors first reported a position in Vicarious Surgical in Q4 2020 and held it in 2 quarters.
  • Ramius Advisors's Vicarious Surgical position peaked at $5.95M in Q4 2020.
  • 98 funds tracked by Wall St. Rank held Vicarious Surgical as of Q2 2021.

Based on Ramius Advisors's 13F filing for Q2 2021, filed 11 Aug 2021.